EE14 Cost of Care Comparison of Elranatamab-bcmm and Teclistamab-cqyv in Adult Patients with Relapsed or Refractory Multiple Myeloma (RRMM).
- Resource Type
- Article
- Source
Value in Health . 2024 Supplement, Vol. 27 Issue 6, pS59-S59. 1p.- Subject
- Language
- ISSN
- 1098-3015